Rizawati Ramli graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Malaya in 2003. Until 2012, she worked in various specialties in the hospital. During this period, she obtained a master’s degree in Family Medicine, Malaysia after which she worked as Family Medicine Specialist in several Ministry of Health (MOH) public primary care clinics. She has vast experience working closely with the community across various ethnicity and different socioeconomic statuses including indigenous and marginalised people in East Malaysia. In 2015, she received a ‘Letter of Appreciation from National Population Fund (UNFPA), United Nation’ for the Maternal and Child Health service she oversaw in districts of Sabah. Non-communicable diseases, thalassemia screening programmes and children with special needs were areas she spent much in while working in primary care MOH. In 2019 she contributed to the writing of the National Health and Morbidity Survey (NHMS) report for Diabetes, Hypertension and Hypercholesterolemia. She also had an opportunity to be part of the medical team for the Malaysia Hajj Operation in 2014 and 2019 as a medical officer. During her service with MOH, she received Distinction in Service Award twice in 2007 and 2014. Besides her commitment to taking care of community health, she also has a passion for sharing her knowledge and experience with the younger generation of doctors and future doctors. She was appointed as an honorary lecturer for MBBS academic session 2018/2019, International Medical School (IMS), Management and Science University (MSU) Shah Alam Campus, trainer of Malaysia-Ireland Post-graduate training in Family Medicine (MInTFM) and supervisor for the Master of Family Medicine post-graduate student. She also has an interest in doing research which has driven her collaboration with the academic universities including Universiti Malaya to conduct a few studies. With her vast experience as a family medicine specialist working on the ground and her interest in clinical teaching and academic research, she decided to join Universiti Malaya as an academic in 2020. Currently, besides her core works as a clinical lecturer and family medicine specialist, she is also part of the post-graduate committee for the Master of Family Medicine, Universiti Malaya, and co-leading of NIHR funded research projects in asthma. Moving on, she plans to venture into implementation science in non communicable diseases including cardiovascular and respiratory diseases.

After serving the government for 31 years, Ar. Zuraina Leily Awalludin retired on 31 August 2015 where her last posting was at the Architectural Branch, Public Works Department (PWD) Malaysia. Amongst her duties then, were heading several design teams providing architectural, interior design and building conservation services for Government funded projects.    She is presently appointed as an Associate Professor (Industry) at the Faculty of Built Environment in University Malaya where she also lectures students in the Masters programme. Further to that, she has currently two architectural practices that is as the director of Acasys Design and Environmental Architects Sdn. Bhd (ADEA), a body corporate practice and the Principal of Zuraina Leily Architect, a sole proprietor practice. For the past few years, she had been appointed to serve as a Board Member and as Registrar where she is actively involved in several Committees at the Board of Architects Malaysia. Presently, she holds a few post that is;  Honorary Secretary to the Council of Architectural Accreditation for Education Malaysia (CAAEM); Committee Member of the Monitoring Committee for APEC Architect Project as well as for ASEAN Architect.  In the international level, she had been involved and represented the profession in many international missions and negotiations especially in the ASEAN region. She played a key role in drafting the Mutual Recognition Arrangement (MRA) for the ASEAN Member States on Architectural Services. In the year 2009 to 2011, she held the post of Honorary Secretary for the Inaugral ASEAN Architect Council. Besides her practice as an Architect and involvement in lecturing students, she is also an accredited Conservator registered with the National Heritage Department Malaysia. In 2016 and 2018, she was elected as Council Member for International Council Of Monuments and Sites (ICOMOS) of Malaysia, which champions the protection of heritage buildings and sites.

Zamri obtained his BSc in Chemistry and MSc in pharmacology from the University of Malaya and later PhD in Clinical Pharmacology from the University of London (UK) in 2007. Soon after completed his doctorate degree, he joined the Department of pharmacology, University of Malaya as a senior lecturer and currently serves as a Professor in the Department of Pharmacology and also Head of Universiti Malaya Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT). He was recently awarded a Fellow by the British Pharmacological Society (FBPhS). His scope of research includes bioavailability and pharmacokinetic studies in human and animal models, drug delivery systems such as PEG-PLGA nanoparticles for systemic drug delivery, and semi solid formulations for transdermal and topical preparation.  Apart from human clinical trials and preclinical studies in animals, his research also covers the development of humanized mice model for cancers and cell based therapy for cancers. His laboratory also provides services and research in adulterated pharmaceutical products, xenobiotic studies on certain chemicals such as endocrine disruptors in food products, human bodies, etc. using GCMS, HPLC, LCMSMS, etc. Apart from his research activities, he also actively provided consultation to local pharmaceutical companies to conduct testing on pharmaceutical formulations especially for bioequivalence studies, comparative dissolution, etc. His bioequivalence laboratory has conducted more than 40 bioequivalence studies for generic drug formulations and also conducted drug analysis in biological and pharmaceutical formulations.